Kimberly-Clark Buying Tylenol Maker Kenvue for $48.7B
Episode

Kimberly-Clark Buying Tylenol Maker Kenvue for $48.7B

**Summary:**Kenvue and Kimberly-Clark announce a major deal, with Kenvue shareholders receiving $21.50 per share in cash and stock. The combined company will be led by Mike Hsu and maintain headquarters in Irving, Texas. The deal is subject to shareholder approval and is expected to close in the second half of next year. Market reactions were mixed, with Kimberly-Clark shares dropping and Kenvue's stock surging. The Daily News Now! - Every city. Every story. AI Powered. Hosted on Acast. See acast.com/privacy for more information.

Community discussion